Owner Takeda Pharmaceutical Company Limited

Inventors Cho, Nobuo; Kasai, Shizuo; Kamaura, Masahiro

Agent Griffith Hack

Pub. Number AU-A-2009252307

PCT Pub. Number WO2009/145286

Priority 61/129,032 30.05.08 US

Filing date 29 May 2009

Wipo publication date 3 December 2009

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/4166 (2006.01)

A61K 31/425 (2006.01) - Thiazoles

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/27 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/273 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 233/34 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 275/02 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 307/16 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom